Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor

Breast Cancer Research and Treatment

Volumn 83, Issue 3, 2004, Pages 233-244

  Efeyan, Alejo ^a   Fabris, Victoria ^a   Merani, Susana ^b   Lanari, Claudia ^a,c   Molinolo, Alfredo A ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Antiprogestins; Breast cancer; Cell lines; Estrogens; Hormone dependence; Hormone receptors; Medroxyprogesterone acetate

Indexed keywords

CYTOKERATIN; ESTRADIOL; MIFEPRISTONE; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CHROMOSOME; CONTROLLED STUDY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 1242353199     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000014044.02728.ac     Document Type: Article

References (36)

1. Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA: Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Cancer Res 61: 293-302, 2001
2. Bernhardt G, Beckenlehner K, Spruss T, Schlemmer R, Reile H, Schonenberger H: Establishment and characterization of new murine breast cancer cell lines. Arch Pharm (Weinheim) 335: 55-68, 2002
3. Lanari C, Molinolo AA, Pasqualini CD: Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer Lett 33: 215-223, 1986
4. Molinolo AA, Lanari C, Charreau EH, Sanjuan N, Pasqualini CD: Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J Natl Cancer Inst 79: 1341-1350, 1987
5. Kordon E, Lanari C, Meiss R, Charreau E, Pasqualini CD: Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast Cancer Res Treat 17: 33-43, 1990
6. Dran G, Luthy IA, Molinolo AA, Charreau EH, Pasqualini CD, Lanari C: Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast Cancer Res Treat 35: 173-186, 1995
7. Kordon E, Lanari C, Molinolo AA, Elizalde PV, Charreau EH, Pasqualini CD: Estrogen inhibition of MPA-induced mouse mammary tumor transplants. Int J Cancer 49: 900-905, 1991
8. Montecchia MF, Lamb C, Molinolo AA, Luthy IA, Pazos P, Charreau E, Vanzulli S, Lanari C: Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas. J Steroid Biochem Mol Biol 68: 11-21, 1999
9. Vanzulli S, Efeyan A, Benavides F, Helguero L, Peters G, Shen J, Conti CJ, Lanari C, Molinolo A: p21, p27 and p53 in estrogen and antiprogestin- induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis 23: 749-757, 2002
10. Seabright M: A rapid banding technique for human chromosomes. Lancet 2: 971-972, 1971
11. Commitee on Standardized Genetic Nomenclature for mice: Standard karyotype of the mouse, Mus musculus. J Hered 63: 69-72, 1972
12. Lowry OH, Rosebrough NJ, Fair AL: Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
13. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
14. Sizemore SR, Cole RD: A test for hormonal responsiveness in a mammary epithelial cell line, NMuMg. In vitro 18: 668-674, 1982
15. Institute of Laboratory Animal Resources, Commission on Life Sciences National Research Council. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC, 1996
16. Helguero L, Viegas MH, Asaithamby A, Shyamala G, Lanari C, Molinolo A: Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment. Breast Cancer Res Treat, 2003
17. Masamura S, Santner SJ, Heitjan DF, Santen RJ: Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80: 2918-2925, 1995
18. Chun TY, Gregg D, Sarkar DK, Gorski J: Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth. Proc Natl Acad Sci USA 95: 2325-2330, 1998
19. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S, Kawashima H: Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 235: 99-102, 1997
20. Bentel JM, Birrell SN, Pickering MA, Holds DJ, Horsfall DJ, Tilley WD: Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol Cell Endocrinol 154: 11-20, 1999
21. Classen S, Possinger K, Pelka-Fleischer R, Wilmanns W: Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells. J Steroid Biochem Mol Biol 45: 315-319, 1993
22. Sutherland RL, Hall RE, Pang GY, Musgrove EA, Clarke CL: Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res 48: 5084-5091, 1988
23. Hissom JR, Bowden RT, Moore MR: Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D. Endocrinology 125: 418-423, 1989
24. Hackenberg R, Luttchens S, Hofmann J, Kunzmann R, Holzel F, Schulz KD: Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res 51: 5722-5727, 1991
25. Hackenberg R, Hawighorst T, Filmer A, Nia AH, Schulz KD: Medroxyprogesterone acetate inhibits the proliferation of estrogen-and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. Breast Cancer Res Treat 25: 217-224, 1993
26. Lin VC, Eng AS, Hen NE, Ng EH, Chowdhury SH: Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231. Clin Cancer Res 7: 2880-2886, 2001
27. Levenson AS, Jordan VC: Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J Steroid Biochem Mol Biol 51: 229-239, 1994
28. Thomas M, Monet JD: Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line. J Clin Endocrinol Metab 75: 865-870, 1992
29. Bardon S, Vignon F, Chalbos D, Rochefort H: RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor. J Clin Endocrinol Metabolism 60: 692-697, 1985
30. Klijn JG, Setyono-Han B, Foekens JA: Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer. Steroids 65: 825-830, 2000
31. Moreno-Cuevas JE, Sirbasku DA: Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications. In vitro Cell Dev Biol Anim 36: 410-427, 2000
32. Soto AM, Sonnenschein C: Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev 8: 44-52, 1987
33. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD, Shay JW: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78: 766-774, 1998
34. Truong K, Guilly MN, Gerbault-Seureau M, Malfoy B, Vielh P, Dutrillaux B: Evidence for in vitro selection during cell culturing of breast cancer: detection by flow and image cytometry. Cancer Genet Cytogenet 114: 154-155, 1999
35. Fabris V, Lamb C, Keck C, Aldaz CM, Merani S, Lanari C: Karyotypic evolution of four novel mouse mammary carcinoma cell lines: identification of marker chromosomes by FISH. Cancer Genet Cytogenet, 2003
36. Dietrich WF, Radany EH, Smith JS, Bishop JM, Hanahan D, Lander ES: Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Proc Natl Acad Sci USA 91: 9451-9455, 1994